CDKV Holdings’s Pfizer PFE Stock Holding History

CDKV Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$194K	Hold	8,047	–	–	0.15%	72
2026 Q1	$226K	Hold	8,047	–	–	0.2%	65
2025 Q4	$200K	Buy	+8,047	New	+$203K	0.17%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CDKV Holdings's PFE Position: Q2 2026 in Review

CDKV Holdings held its Pfizer (PFE) position steady in Q2 2026 at 8,047 shares worth $194K. The position accounts for 0.15% of the portfolio, ranked #72.

CDKV Holdings first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $226K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

CDKV Holdings held 8,047 shares of Pfizer worth $194K as of Q2 2026.
CDKV Holdings left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.15% of CDKV Holdings's portfolio in Q2 2026, its #72 holding.
CDKV Holdings first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
CDKV Holdings's Pfizer position peaked at $226K in Q1 2026.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.